glutathione package insert Drug Facts Maxiliv 600 MG Injection |

Curr Mol Biol Rep

10.1038/s41420-022-01297-7 126 DuY

These candidate vaccines are LNP-encapsulated mRNA-based formulations that encode the full-length SARS-CoV-2 spike protein and its receptor-binding domain

Kumar A, Dubey AK, Kumar V et al (2020a) Over-expression of chickpea glutaredoxin (CaGrx) provides tolerance to heavy metals by reducing metal accumulation and improved physiological and antioxidant defence system

Loading Phase (Weeks 1 through 4) Tb-500: 2 to 2.5 mg twice weekly (Monday and Thursday) totaling 4 to 5 mg per week Bpc-157: 0.5 mg daily, either as single dose or split into 0.25 mg twice daily Maintenance Phase (Weeks 5 through 8 plus) Tb-500: 2 mg once weekly Bpc-157: 0.25 to 0.5 mg daily Critical Notes Use separate vials and syringes for each peptide Never mix Bpc-157 and Tb-500 in the same syringe Tb-500 can be injected anywhere subcutaneously Bpc-157 should ideally be injected near the injury site The critical implementation detail bears repeating: Bpc-157 and Tb-500 should never be combined into a single vial as peptides lose their effectiveness when mixed incorrectly